Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1999
10/28/1999WO1999054486A1 Canine erythropoietin gene and recombinant protein
10/28/1999WO1999054485A1 A method for inhibiting tumor invasion or spreading in a subject
10/28/1999WO1999054482A1 Dna fragmentation factor involved in apoptosis
10/28/1999WO1999054480A1 Transgenic plants presenting a modified inulin producing profile
10/28/1999WO1999054474A2 Bacterial yiha polypeptide family
10/28/1999WO1999054473A2 Bacterial yjeq polypeptide family
10/28/1999WO1999054472A1 Novel insecticidal toxins from xenorhabdus nematophilus and nucleic acid sequences coding therefor
10/28/1999WO1999054471A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata
10/28/1999WO1999054470A2 Bacterial ygjd polypeptide family
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054468A1 Soluble protein ztmpo-1
10/28/1999WO1999054467A1 Sh2 domain-containing peptides
10/28/1999WO1999054466A2 Colon cancer-associated antigens and their diagnostic and therapeutic uses
10/28/1999WO1999054465A2 Gene encoding syntaxin interacting protein
10/28/1999WO1999054464A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054462A2 Bacterial ycfb polypeptide family
10/28/1999WO1999054461A2 Human nucleic acid sequences of endometrium tumour tissue
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue
10/28/1999WO1999054457A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
10/28/1999WO1999054456A1 ANTISENSE OLIGONUCLEOTIDES FOR THE INHIBITION OF INTEGRIN αv-SUBUNIT EXPRESSION
10/28/1999WO1999054452A1 Methods and substances for preventing and treating autoimmune disease
10/28/1999WO1999054451A1 Neuroendocrine cells secreting insulin ans uses thereof
10/28/1999WO1999054448A2 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue
10/28/1999WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999WO1999054446A2 Human nucleic acid sequences which are overexpressed in normal pancreas tissue
10/28/1999WO1999054441A1 Efficient purification of adenovirus
10/28/1999WO1999054437A2 Novel molecules of the t125-related protein family and uses thereof
10/28/1999WO1999054436A2 Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof
10/28/1999WO1999054360A1 Substance with antithrombotic activity and method for detecting glycokallidin
10/28/1999WO1999054359A1 Matrix binding factor
10/28/1999WO1999054358A1 Melanocortin receptor ligands
10/28/1999WO1999054357A1 Novel cytokine-like protein
10/28/1999WO1999054356A1 Peptide fragments of murine epidermal growth factor as laminin receptor targets
10/28/1999WO1999054355A1 Process for the recovery and purification of a recombinant protein from a cell
10/28/1999WO1999054354A1 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it
10/28/1999WO1999054353A2 Human nucleic acid sequences of normal uterus tissue
10/28/1999WO1999054352A2 Srebp-1 and srebp-2 in a phosphorylated form
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054350A1 Novel omega conotoxin peptides
10/28/1999WO1999054349A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999WO1999054348A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999WO1999054347A2 ALZHEIMER-ASSOCIATED β-AMYLOID BINDING PROTEIN (ERAB)
10/28/1999WO1999054345A1 Cd8 antagonists
10/28/1999WO1999054343A2 Novel molecules of the t139-related protein family and uses thereof
10/28/1999WO1999053961A1 Peptides for efficient gene transfer
10/28/1999WO1999053953A2 Methods and products related to metabolic interactions in disease
10/28/1999WO1999053948A1 Chlamydia proteins and their uses
10/28/1999WO1999053946A1 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
10/28/1999WO1999053942A1 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
10/28/1999WO1999053940A1 PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR
10/28/1999WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
10/28/1999WO1999053931A1 Tumor cells with increased immunogenicity and uses thereof
10/28/1999WO1999053762A1 A method for efficient and highly selective control of microorganisms
10/28/1999WO1999053743A2 Novel genes and methods that modulate apoptosis
10/28/1999WO1999043812A3 Dlc-1 gene, a putative tumors suppressor gene
10/28/1999WO1999042839A3 Treating cancer
10/28/1999WO1999042580A8 Gaba receptors and their uses
10/28/1999WO1999042127A3 Receptor derived peptides as modulators of receptor activity
10/28/1999WO1999041404A3 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
10/28/1999WO1999041379A9 Members of the d52 gene family
10/28/1999WO1999041378A9 Members of the d52 gene family
10/28/1999WO1999041279A3 Methods and compositions comprising the use of blocked b-amyloid peptide
10/28/1999WO1999040946A3 Methods and compositions for modulating leptin activity
10/28/1999WO1999040112A9 Neuroprotective peptides and uses thereof
10/28/1999WO1999038977A3 Plant having altered environmental stress tolerance
10/28/1999WO1999037763A9 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
10/28/1999WO1999037299B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/28/1999WO1999036441A3 Haemopoietic stem cell inhibitor(s)
10/28/1999WO1999032516A3 Pharmaceutical compositions containing the long pentraxin ptx3
10/28/1999WO1999029341A3 Methods for enhancement of protective immume responses employing leishmania polypeptides
10/28/1999WO1999027080A3 Human protein kinase and kinase inhibitors
10/28/1999WO1999024463A3 Signal peptide-containing proteins
10/28/1999WO1999008695A8 FLUORESCENT AMYLOID Aβ PEPTIDES AND USES THEREOF
10/28/1999WO1999005272A9 Use of transcription factor brn-3a
10/28/1999WO1998044104A3 Flip gene and flip protein
10/28/1999WO1998040099A9 Leptospira pathogens
10/28/1999DE19903693A1 Protease zur Aktivierung des Gerinnungsfaktors VII Protease for activation of coagulation factor VII
10/28/1999DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
10/28/1999DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents
10/28/1999DE19817947A1 New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents
10/28/1999DE19816902A1 New phosphorylated forms of sterol regulatory element binding proteins useful for treating or preventing arteriosclerosis, stroke and diabetes mellitus
10/28/1999CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999CA2329302A1 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
10/28/1999CA2328967A1 A method for efficient and highly selective control of microorganisms
10/28/1999CA2328888A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999CA2328463A1 Matrix binding factor
10/28/1999CA2328399A1 Pneumococcal surface protein c(pspc), epitopic regions and strain selection thereof, and uses therefor
10/28/1999CA2326689A1 Stress tolerant plants
10/28/1999CA2326670A1 Ikb and enhanced green fluorescent fusion protein
10/28/1999CA2326623A1 Gene encoding syntaxin interacting protein
10/28/1999CA2326384A1 Canine erythropoietin gene and recombinant protein
10/28/1999CA2326067A1 Novel insecticidal toxins from xenorhabdus nematophilus and nucleic acid sequences coding therefor
10/28/1999CA2326002A1 Chlamydia proteins and their uses
10/28/1999CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
10/28/1999CA2325848A1 B-cell growth factor related protein
10/28/1999CA2325822A1 Soluble protein ztmpo-1
10/28/1999CA2325821A1 Antisense oligonucleotides for the inhibition of integrin .alpha.v-subunit expression
10/28/1999CA2325663A1 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
10/28/1999CA2325573A1 A method for inhibiting tumor invasion or spreading in a subject
1 ... 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 ... 2916